These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1646420)

  • 21. Delta 9-tetrahydrocannabinol sensitization of the rat brain to direct cholinergic stimulation.
    Duncan GE; Dagirmanjian R
    Psychopharmacology (Berl); 1979 Feb; 60(3):237-40. PubMed ID: 108700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of dopaminergic and cholinergic drugs. naloxone and l-prolyl-leucyl-glycinamide on LSD-induced catalepsy.
    Chiu S; Mishra RK
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(1):45-50. PubMed ID: 6111027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions between oxotremorine and inhibitors of cholinesterase enzymes.
    Cox B; Tha SJ
    J Pharm Pharmacol; 1973 Jul; 25(7):544-9. PubMed ID: 4147051
    [No Abstract]   [Full Text] [Related]  

  • 24. Nonmuscarinic neurotoxicity of oxotremorine.
    Witkin JM; Alvarado-Garcia R; Lee MA; Witkin KM
    J Pharmacol Exp Ther; 1987 Apr; 241(1):34-41. PubMed ID: 3572794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered pilocarpine- or chlorpromazine-induced catalepsy after long-term treatment with cholinergic drugs.
    Gianutsos G
    Psychopharmacology (Berl); 1979 Nov; 66(2):121-5. PubMed ID: 119254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholinergic inhibition of acetylcholine release in the electric organ of Torpedo.
    Dunant Y; Walker AI
    Eur J Pharmacol; 1982 Feb; 78(2):201-12. PubMed ID: 6281033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production of analgesia by cholinergic drugs.
    Dayton HE; Garrett RL
    Proc Soc Exp Biol Med; 1973 Mar; 142(3):1011-3. PubMed ID: 4691997
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of vasopressin V1a receptor in ∆
    Egashira N; Koushi E; Myose T; Tanoue A; Mishima K; Tsuchihashi R; Kinjo J; Tanaka H; Morimoto S; Iwasaki K
    Psychopharmacology (Berl); 2017 Dec; 234(23-24):3475-3483. PubMed ID: 28905207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of cholinergic agonists and antagonists on jumping behaviour induced by morphine and L-dopa in mice.
    Pillai NP; Ramaswamy S; Gopalakrishnan V; Ghosh MN
    Indian J Exp Biol; 1984 Jan; 22(1):59-60. PubMed ID: 6746026
    [No Abstract]   [Full Text] [Related]  

  • 30. Cholinergic mechanisms and cataplexy in dogs.
    Delashaw JB; Foutz AS; Guilleminault C; Dement WC
    Exp Neurol; 1979 Dec; 66(3):745-57. PubMed ID: 573697
    [No Abstract]   [Full Text] [Related]  

  • 31. Regulation of histamine turnover via muscarinic and nicotinic receptors in the brain.
    Oishi R; Adachi N; Okada K; Muroi N; Saeki K
    J Neurochem; 1990 Dec; 55(6):1899-904. PubMed ID: 1700067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tetrahydrocannabinol potentiates reserpine-induced hypokinesia.
    Moss DE; McMaster SB; Rogers J
    Pharmacol Biochem Behav; 1981 Nov; 15(5):779-83. PubMed ID: 6273940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delta 9-tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons.
    Sano K; Mishima K; Koushi E; Orito K; Egashira N; Irie K; Takasaki K; Katsurabayashi S; Iwasaki K; Uchida N; Egawa T; Kitamura Y; Nishimura R; Fujiwara M
    Neuroscience; 2008 Jan; 151(2):320-8. PubMed ID: 18083311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholinergic modulation of the content of temporal memory.
    Meck WH; Church RM
    Behav Neurosci; 1987 Aug; 101(4):457-64. PubMed ID: 2820435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
    Varvel SA; Bridgen DT; Tao Q; Thomas BF; Martin BR; Lichtman AH
    J Pharmacol Exp Ther; 2005 Jul; 314(1):329-37. PubMed ID: 15831444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Participation of the cholinergic system in temperature regulation by the mouse].
    Staib AH; Schröder M
    Arch Int Pharmacodyn Ther; 1971 Jul; 192(1):88-95. PubMed ID: 5093196
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of drugs and axotomy on acetylcholine levels in central cholinergic neurons.
    Rommelspacher H; Kuhar MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 291(1):17-21. PubMed ID: 172807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of cholinergic drugs on acute and chronic morphine dependence.
    Padmanabha Pillai N; Ramaswamy S; Gopalakrishnan V; Ghosh MN
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):146-54. PubMed ID: 7202346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid induction of supersensitivity to muscarinic antagonists-induced motor excitation by continuous stimulation of cholinergic receptors.
    Fernando JC; Hoskins B; Ho IK
    Life Sci; 1985 Sep; 37(9):883-92. PubMed ID: 4041002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Muscarinic receptors on dopamine terminals in the cat caudate nucleus: neuromodulation of [3H]dopamine release in vitro by endogenous acetylcholine.
    Lehmann J; Langer SZ
    Brain Res; 1982 Sep; 248(1):61-9. PubMed ID: 6289994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.